Phio Pharmaceuticals (PHIO) Revenue & Revenue Breakdown
Phio Pharmaceuticals Revenue Highlights
Phio Pharmaceuticals Revenue by Period
Phio Pharmaceuticals Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | - | 100.00% |
| 2022-12-31 | - | 100.00% |
| 2021-12-31 | - | 100.00% |
| 2020-12-31 | - | -100.00% |
| 2019-12-31 | $21.00K | -84.78% |
| 2018-12-31 | $138.00K | 820.00% |
| 2017-12-31 | $15.00K | -21.05% |
| 2016-12-31 | $19.00K | -44.12% |
| 2015-12-31 | $34.00K | -52.11% |
| 2014-12-31 | $71.00K | -82.21% |
| 2013-12-31 | $399.00K | 311.34% |
| 2012-12-31 | $97.00K | 100.00% |
| 2011-12-31 | - | - |
Phio Pharmaceuticals generated - in revenue during NA 2023, up 100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.
Phio Pharmaceuticals Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-06-30 | - | 100.00% |
| 2024-03-31 | - | -100.00% |
| 2023-12-31 | $30.00K | 100.00% |
| 2023-09-30 | - | 100.00% |
| 2023-06-30 | - | 100.00% |
| 2023-03-31 | - | 100.00% |
| 2022-12-31 | - | 100.00% |
| 2022-09-30 | - | 100.00% |
| 2022-06-30 | - | 100.00% |
| 2022-03-31 | - | 100.00% |
| 2021-12-31 | - | 100.00% |
| 2021-09-30 | - | 100.00% |
| 2021-06-30 | - | 100.00% |
| 2021-03-31 | - | 100.00% |
| 2020-12-31 | - | 100.00% |
| 2020-09-30 | - | 100.00% |
| 2020-06-30 | - | 100.00% |
| 2020-03-31 | - | 100.00% |
| 2019-12-31 | - | 100.00% |
| 2019-09-30 | - | 100.00% |
| 2019-06-30 | - | -100.00% |
| 2019-03-31 | $21.00K | 100.00% |
| 2018-12-31 | - | -100.00% |
| 2018-09-30 | $57.00K | -1.72% |
| 2018-06-30 | $58.00K | 152.17% |
| 2018-03-31 | $23.00K | 53.33% |
| 2017-12-31 | $15.00K | 100.00% |
| 2017-09-30 | - | 100.00% |
| 2017-06-30 | - | 100.00% |
| 2017-03-31 | - | 100.00% |
| 2016-12-31 | - | 100.00% |
| 2016-09-30 | - | -100.00% |
| 2016-06-30 | $9.00K | -10.00% |
| 2016-03-31 | $10.00K | 100.00% |
| 2015-12-31 | - | 100.00% |
| 2015-09-30 | - | 100.00% |
| 2015-06-30 | - | -100.00% |
| 2015-03-31 | $34.00K | 142.86% |
| 2014-12-31 | $14.00K | -12.50% |
| 2014-09-30 | $16.00K | 33.33% |
| 2014-06-30 | $12.00K | -58.62% |
| 2014-03-31 | $29.00K | - |
| 2013-12-31 | $29.00K | -68.48% |
| 2013-09-30 | $92.00K | -59.11% |
| 2013-06-30 | $225.00K | 324.53% |
| 2013-03-31 | $53.00K | 32.50% |
| 2012-12-31 | $40.00K | -29.82% |
| 2012-09-30 | $57.00K | 100.00% |
| 2012-06-30 | - | 100.00% |
| 2012-03-31 | - | 100.00% |
| 2011-12-31 | - | 100.00% |
| 2011-09-30 | - | 100.00% |
| 2011-06-30 | - | 100.00% |
| 2011-03-31 | - | - |
Phio Pharmaceuticals generated - in revenue during Q2 2024, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.
Phio Pharmaceuticals Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| VECT | VectivBio | $27.34M | $676.00K |
| SONN | Sonnet BioTherapeutics | $147.81K | - |
| CWBR | CohBar | - | - |
| AVRO | AVROBIO | - | - |
| CNSP | CNS Pharmaceuticals | - | - |
| ZURA | Zura Bio | - | - |
| ELEV | Elevation Oncology | - | - |
| ATNF | 180 Life Sciences | - | - |
| PHIO | Phio Pharmaceuticals | - | - |
| ZVSA | ZyVersa Therapeutics | - | - |
| OCEA | Ocean Biomedical | - | - |
| IMMX | Immix Biopharma | - | - |
| EFTR | eFFECTOR Therapeutics | - | - |
| CDIO | Cardio Diagnostics | - | $7.87K |
PHIO Revenue FAQ
What is Phio Pharmaceuticals’s yearly revenue?
Phio Pharmaceuticals's yearly revenue for 2023 was $0, representing an increase of 100.00% compared to 2022. The company's yearly revenue for 2022 was $0, representing an increase of 100.00% compared to 2021. PHIO's yearly revenue for 2021 was $0, representing an increase of 100.00% compared to 2020.
What is Phio Pharmaceuticals’s quarterly revenue?
Phio Pharmaceuticals's quarterly revenue for Q2 2024 was $0, a 100.00% increase from the previous quarter (Q1 2024), and a 0% increase year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $0, a -100.00% decrease from the previous quarter (Q4 2023), and a 0% increase year-over-year (Q1 2023). PHIO's quarterly revenue for Q4 2023 was $30K, a 100.00% increase from the previous quarter (Q3 2023), and a 0% increase year-over-year (Q4 2022).
What is Phio Pharmaceuticals’s revenue growth rate?
Phio Pharmaceuticals's revenue growth rate for the last 3 years (2021-2023) was 0%, and for the last 5 years (2019-2023) was -100.00%.